Clear cell adenocarcinoma with a component of poorly differentiated histology: A poor prognostic subgroup of ovarian clear cell adenocarcinoma

International Journal of Gynecological Pathology

Volumn 30, Issue 5, 2011, Pages 431-441

  Yamamoto, Sohei ^a   Tsuda, Hitoshi ^a,h   Shimazaki, Hideyuki ^a   Takano, Masashi ^a   Yoshikawa, Tomoyuki ^a   Kuzuya, Kazuo ^c,i   Tsuda, Hiroshi ^d,j   Kurachi, Hirohisa ^e   Kigawa, Junzo ^f   Kikuchi, Yoshihiro ^b   Sugiyama, Toru ^g   Matsubara, Osamu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Ohki Memorial Kikuchi Cancer Clinic for Women   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

^e YAMAGATA UNIVERSITY   (Japan)

^f TOTTORI UNIVERSITY HOSPITAL   (Japan)

^g IWATE MEDICAL UNIVERSITY   (Japan)

^h NATIONAL CANCER CENTER HOSPITAL   (Japan)

ⁱ Kuzuya Clinic   (Japan)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Clear cell adenocarcinoma; Grade; Histologic grading; Ovarian cancer; Prognosis

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IRINOTECAN; MITOMYCIN C; PACLITAXEL; VINBLASTINE;

ADULT; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CLEAR CELL CARCINOMA; CONSENSUS; DIFFERENTIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; PATHOLOGIST; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SURVIVAL RATE; TREATMENT RESPONSE; WILCOXON SIGNED RANKS TEST;

ADENOCARCINOMA, CLEAR CELL; CELL DIFFERENTIATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 80051783114     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3182165eba     Document Type: Article

References (24)

1. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag; 2001:791-904.
2. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000;88:2584-9.
3. Ikeda K, Sakai K, Yamamoto R, et al. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer. Int J Gynecol Cancer 2003;13:776-84.
4. Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
5. Kaku T, Ogawa S, Kawano Y, et al. Histological classification of ovarian cancer. Med Electron Microsc 2003;36:9-17.
6. Gynecologic Cancer Committee. Gynecologic cancer comittee, Japan society of obstetrics and gynecology. Annual report of gynecological cancer patients in Japan 2006 (in Japanese). Acta Obstetrica et Gynecologica Japonica 2008;60:1001-85.
7. Crozier MA, Copeland LJ, Silva EG, et al. Clear cell carcinoma of the ovary: A study of 59 cases. Gynecol Oncol 1989; 35:199-203.
8. Kennedy AW, Biscotti CV, Hart WR, et al. Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma. Gynecol Oncol 1993;50:334-8.
9. Omura GA, Brady MF, Homesley HD, et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience. J Clin Oncol 1991;9:1138-50.
10. Chan JK, Teoh D, Hu JM, et al. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008;109:370-6.
11. Mizuno M, Kikkawa F, Shibata K, et al. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. J Surg Oncol 2006;94:138-43.
12. O'Brien ME, Schofield JB, Tan S, et al. Clear cell epithelial ovarian cancer (mesonephroid): Bad prognosis only in early stages. Gynecol Oncol 1993;49:250-4.
13. TakanoM,Kikuchi Y, YaegashiN, et al. Clear cell carcinoma of the ovary: A retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 2006;94:1369-74.
14. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
15. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma: Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 1998;82:893-901.
16. Sato Y, Shimamoto T, Amada S, et al. Prognostic value of histologic grading of ovarian carcinomas. Int J Gynecol Pathol 2003;22:52-6.
17. Ryu SY, Park SI, Nam BH, et al. Prognostic significance of histological grade in clear-cell carcinoma of the ovary: A retrospective of Korean Gynecologic Oncology Group. Ann Oncol 2009;20:1032-6.
18. Yamamoto S, Kasajima A, Takano M, et al. Validation of the histological grading for ovarian clear-cell adenocarcinoma: A retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group. Int J Gynecol Pathol 2010;30: 129-138.
19. Montag AG, Jenison EL, Griffiths CT, et al. Ovarian clear cell carcinoma: A clinicopathologic analysis of 44 cases. Int J Gynecol Pathol 1989;8:85-96.
20. Imachi M, Tsukamoto N, Shimamoto T, et al. Clear cell carcinoma of the ovary: A clinicopathologic analysis of 34 cases. Int J Gynecol Cancer 1991;1:113-9.
21. Scully RE, Young RH, Clement PB. Clear cell tumors. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. Third Series Fascicle 23. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Washington, DC: Armed Forced Institute of Pathology; 1998:141-51.
22. Sakuragi N, Yamada H, Oikawa M, et al. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Gynecol Oncol 2000;79:251-5.
23. Negishi H, Takeda M, Fujimoto T, et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol 2004;94:161-6.
24. Onda T, Yoshikawa H, Yasugi T, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients. Cancer 1998;83:1555-60.